These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33275275)

  • 1. Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
    Alsharif MH; Alsharif YH; Albreem MA; Jahid A; Solyman AAA; Yahya K; Alomari OA; Hossain MS
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11977-11981. PubMed ID: 33275275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
    Miller-Handley H; Luckett K; Govil A
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):434-441. PubMed ID: 33308510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of SARS-CoV-2: How far have we reached?
    Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
    Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicines for the Treatment Of COVID-19: Awaiting the Evidence.
    Marto N; Monteiro EC
    Acta Med Port; 2020 Jul; 33(7-8):500-504. PubMed ID: 32425152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
    Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence.
    Baroutjian A; Sanchez C; Boneva D; McKenney M; Elkbuli A
    Am J Emerg Med; 2020 Nov; 38(11):2405-2415. PubMed ID: 33041111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
    Choudhury M; Dhanabalan AK; Goswami N
    J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 14. Some drugs for COVID-19.
    Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
    [No Abstract]   [Full Text] [Related]  

  • 15. One year update on the COVID-19 pandemic: Where are we now?
    Mishra SK; Tripathi T
    Acta Trop; 2021 Feb; 214():105778. PubMed ID: 33253656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
    Yadav AK; Wen S; Xu X; Yu L
    Ann Palliat Med; 2021 Jan; 10(1):707-720. PubMed ID: 33440983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
    Raj CTD; Kandaswamy DK; Danduga RCSR; Rajasabapathy R; James RA
    Arch Microbiol; 2021 Jul; 203(5):2043-2057. PubMed ID: 33555378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What if COVID-19 affects the child: which weapons and how to use them.
    Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
    Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
    Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.